IP Library Granted Patent US 7,662,932
Granted Patent B2
US 7,662,932 · App. 11/772,089 · Granted Feb 16, 2010

Vascular endothelial growth factor D (VEGF-D) polypeptides and methods of use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,662,932
App. No.
11/772,089
Granted
Feb 16, 2010
Kind
B2
Abstract

The present invention provides VEGF-D polypeptides, which among other things stimulate endothelial cell proliferation and angiogenesis and increases vascular permeability, as well as fragments, dimers, and methods of using the same.

Claims (4)

1. An isolated polypeptide that has at least one activity selected from the group consisting of stimulation of endothelial cell proliferation, stimulation of vascular permeability, binding to the extracellular domain of VEGFR-2, and binding to the extracellular domain of VEGFR-3;

wherein the polypeptide comprises a fragment of the amino acid sequence of SEQ ID NO: 5, wherein said fragment and said polypeptide lack amino acids of SEQ ID NO: 5 that are N- and C- terminal to residues 92-205.

2. The isolated polypeptide of claim 1 that comprises at least amino acids 101-196 of SEQ ID NO: 5.

3. The isolated polypeptide of claim 2 that lacks amino acids of SEQ ID NO: 5 that are N- and C- terminal to residues 93-201.

Assignments (2)
CHANGE OF NAME Recorded Jan 3, 2013
From: VEGENICS LIMITED
To: VEGENICS PTY LTD
Reel/Frame 029565/0926 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2007
From: LUDWIG INSTITUTE FOR CANCER RESEARCH; LICENTIA LTD.
To: VEGENICS LIMITED
Reel/Frame 020243/0259 →